Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Total 13F shares
-
88,419,309
-
Share change
-
-1,210,001
-
Total reported value
-
$7,789,441,265
-
Put/Call ratio
-
78%
-
Price per share
-
$88.10
-
Number of holders
-
322
-
Value change
-
-$73,607,084
-
Number of buys
-
183
-
Number of sells
-
138
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q1 2019
As of 31 Mar 2019 NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) had 322 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 88,419,309 shares of stock of the company.
Largest 10 holders included FMR LLC, JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, BlackRock Inc., Capital International Investors, PERCEPTIVE ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, BB BIOTECH AG, FRANKLIN RESOURCES INC, and STATE STREET CORP.
This table shows 322 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.